ASX Announcements

Validation for NNZ-2591 neurodevelopmental disorder pipeline
NNZ-2591 positive effects in Pitt Hopkins syndrome model
NNZ-2591 positive effects in Angelman syndrome model
Appendix 4C - quarterly
Notice of Annual General Meeting/Proxy Form
Appendix 4G
Annual Report to shareholders
Update on development plan for NNZ-2591
Neuren's Rett syndrome Phase 2 trial published in Neurology
Fundamentals strong as Neuren advances neuroscience pipeline